Tramadol/paracetamol sustained-release - Yungjin Pharm

Drug Profile

Tramadol/paracetamol sustained-release - Yungjin Pharm

Alternative Names: Paracetamol/tramadol; YJAT sustained release tablet; YJAT-SR

Latest Information Update: 07 Dec 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Yungjin Pharm Co
  • Class Acetanilides; Antipyretics; Cyclohexanols; Dimethylamines; Non-opioid analgesics; Opioid analgesics; Small molecules
  • Mechanism of Action Opioid mu receptor agonists; Prostaglandin receptor antagonists; Serotonin uptake inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preregistration Pain

Most Recent Events

  • 30 Sep 2015 Preregistration for Pain in South Korea (PO)
  • 31 Jan 2012 Phase-I clinical trials in Pain in South Korea (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top